BIO-TECHNE Corp — Director's Dealing 2025

Nov 3, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2025-10-30

Reporting Person: Vessey Rupert (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-10-30	Common Stock	A	1640	—	Acquired	10987	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-10-30	Stock Options (Right to Buy)	$60.96	A	3777	Acquired	2035-10-30	Common Stock (3777)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$50.41	2029-10-24	Common Stock (8044)	8044	Direct
Stock Options (Right to Buy)	$52.32	2029-06-30	Common Stock (2352)	2352	Direct
Stock Options (Right to Buy)	$63.92	2030-10-29	Common Stock (6028)	6028	Direct
Stock Options (Right to Buy)	$128.81	2031-10-28	Common Stock (2532)	2532	Direct
Stock Options (Right to Buy)	$73.94	2032-10-27	Common Stock (3460)	3460	Direct
Stock Options (Right to Buy)	$61.51	2033-10-26	Common Stock (3937)	3937	Direct
Stock Options (Right to Buy)	$68.37	2034-10-24	Common Stock (3511)	3511	Direct

Footnotes

F1: The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.